|
|
Vaccine Detail
|
Pancreatic tumor personalized neoantigen vaccine |
| Vaccine Information |
- Vaccine Name: Pancreatic tumor personalized neoantigen vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: neoantigen (NCT03558945)
- Immunization Route: subcutaneous injection
- Description: Personalized neoantigen peptide-based vaccines are based on next-generation sequencing and major histocompatibility complex affinity prediction algorithm, and may help treat patients with pancreatic ductal adenocarcinoma. This vaccine may elicit measurable neoantigen-specific immunologic responses in patients. (NCT03558945)
|
| Host Response |
|
|
| References |
NCT03558945: Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor [https://clinicaltrials.gov/study/NCT03558945]
|
|
